Check Point Advisories

Symantec Products CLIproxy.dll ActiveX Control Buffer Overflow (CVE-2010-0108)

Check Point Reference: CPAI-2010-132
Date Published: 11 May 2010
Severity: High
Last Updated: Tuesday 11 May, 2010
Source:
Industry Reference:CVE-2010-0108
Protection Provided by:

Security Gateway
R81, R80, R77, R75

Who is Vulnerable?
Vulnerability Description Symantec Antivirus and Symantec Client Security are applications designed to protect organizations from the threat of viruses, malware, and intrusion attempts. Both applications can be deployed in an enterprise network environment, and they both support an anti-virus scanning mechanism, a firewall with centralized management, and an automatic signature update mechanism. A buffer overflow vulnerability exists in multiple Symantec products. The vulnerability is due to lack of boundary checks in the Symantec Client Proxy ActiveX control. This vulnerability can allow remote attackers to execute arbitrary code on a target system by enticing a target user to open a maliciously crafted HTML document.

Protection Overview

This protection will detect and block attempts to exploit this vulnerability.

In order for the protection to be activated, update your Security Gateway product to the latest IPS update. For information on how to update IPS, go to SBP-2006-05, click on Protection tab and select the version of your choice.

Security Gateway R80 / R77 / R75

  1. In the IPS tab, click Protections and find the Symantec Products CLIproxy.dll ActiveX Control Buffer Overflow protection using the Search tool and Edit the protection's settings.
  2. Install policy on all Security Gateways.

This protection's log will contain the following information:

Attack Name:  Web Client Enforcement Violation.
Attack Information:  Symantec products CLIproxy.dll ActiveX control buffer overflow

×
  Feedback
This website uses cookies for its functionality and for analytics and marketing purposes. By continuing to use this website, you agree to the use of cookies. For more information, please read our Cookies Notice.
OK